Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

hormonal · Mechanism Report

Can high DHT with below-optimal testosterone reflect preferential 5-alpha conversion?

High DHT with lower total and free testosterone can be consistent with increased conversion, but it is not a validated way to diagnose 5-alpha-reductase activity or rule out testosterone deficiency.

UnsupportedAugust 24, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Testosterone is converted to dihydrotestosterone by 5-alpha-reductase, so high dihydrotestosterone with below-optimal total and free testosterone can reflect preferential 5-alpha conversion rather than simple testosterone deficiency.

laying out figure…
1 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says testosterone can be converted to dihydrotestosterone by 5-alpha-reductase, so a pattern of high DHT with lower testosterone may look like preferential conversion. The evidence frame supports the underlying biochemical pathway, but it also notes that serum DHT and the DHT:testosterone ratio are affected by multiple factors and do not reliably identify tissue-level enzyme activity. As a result, the pattern is described as mechanistically plausible but not diagnostic.

Verified conclusion

Testosterone is the obligate substrate for DHT production, but a serum DHT–testosterone pattern should not be treated as a diagnostic readout of 5-alpha-reductase activity or of hypogonadism.

Mechanistic evidence

  • 5-alpha-reductase directly converts testosterone to DHT through an irreversible, NADPH-dependent reaction. Type 1 (SRD5A1) and type 2 (SRD5A2) have differing tissue expression; DHT has greater androgen-receptor potency than testosterone.
  • Human causal data are strong: finasteride (primarily type-2 inhibition) reduced serum DHT by about 71–73% in randomized studies, while dutasteride (type-1 and type-2 inhibition) reduced it by approximately 94–95%. Pathogenic SRD5A2 variants likewise reduce DHT production, especially in genital tissues.

Interpreting high DHT with lower testosterone

  • Relatively high DHT alongside lower total and free testosterone is mechanistically compatible with increased conversion, but it is only one possible explanation. Serum DHT and the DHT:testosterone ratio are influenced by testosterone production, SHBG, sample timing, assay performance, DHT clearance, medications, and tissue-specific enzyme activity.
  • Neither DHT concentration nor the DHT:testosterone ratio has validated thresholds that identify “preferential” 5-alpha conversion in tissues. Thus, the pattern cannot establish that increased conversion is the cause of low testosterone, nor can it rule out testosterone deficiency.
  • Obesity may lower SHBG and therefore total testosterone; in severe obesity it may also suppress the hypothalamic-pituitary-testicular axis and reduce free testosterone.

Clinical implications

  • Hypogonadism requires compatible symptoms plus consistently, unequivocally low repeat fasting morning testosterone. When indicated, free testosterone should be measured by equilibrium dialysis or accurately calculated, rather than by direct analog assay.
  • Bottom line: The biochemical conversion is established, and preferential conversion is a credible hypothesis, but high serum DHT with lower testosterone is not a validated alternative diagnosis to testosterone deficiency.

References

  1. The Effect of 5α-Reductase Inhibition With Dutasteride ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. Comparison of Clinical Trials With Finasteride and Dutasteride - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Phenotype, genotype and gender identity in a large cohort ... — pubmed.ncbi.nlm.nih.gov ↗
  4. The Molecular Basis of 5α-Reductase Type 2 Deficiency - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  5. 5α-Reductase Deficiency - StatPearls - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  6. Testosterone Therapy for Hypogonadism Guideline Resources — endocrine.org ↗
  7. [PDF] An Endocrine Society Clinical Practice Guideline - Semantic Scholar — pdfs.semanticscholar.org ↗
  8. Endocrine Society GUIDELINES Bundle (free trial) - Testosterone ... — eguideline.guidelinecentral.com ↗
  9. The Genotype-Phenotype Correlation in Human 5α-Reductase Type 2 Deficiency: Classified and Analyzed from a SRD5A2 Structural Perspective — pmc.ncbi.nlm.nih.gov ↗
  10. Low Testosterone Concentrations in Men With Obesity | The ... — academic.oup.com ↗
  11. Lowered testosterone in male obesity: mechanisms, morbidity ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible11 sourcesCan reduced thyroid hormone signaling lower energy and muscle function?→Plausible8 sourcesDoes the menopause transition worsen body composition even if weight rises?→